Ignite Creation Date:
2024-05-06 @ 8:25 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06371807
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-17
First Post:
2024-03-12
Brief Title:
Trial for Treatment of High Risk BC With Two Sequences of Neoadjuvant Chemotherapy With Pembrolizumab
Sponsor:
Fundacao Champalimaud
Organization:
Fundacao Champalimaud
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Triple Negative Breast Cancer |
| Early Breast Cancer |
Keywords: